Phenotyping sleep apnoea: morphology and obesity

T. Gislason (Reykjavik, Iceland)

Source: ERS Conference
Number: 89
Disease area: Sleep and breathing disorders

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Gislason (Reykjavik, Iceland). Phenotyping sleep apnoea: morphology and obesity. ERS Conference

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotyping sleep apnoea: cardiovascular aspects and chemosensitivity
Source: ERS Conference
Year: 2015

Phenotyping sleep apnea patients.
Source: 5th Sleep and Breathing Conference
Year: 2019

Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007


Obstructive sleep apnoea syndrome (OSAS) and diabetes: influence of obesity
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study
Source: Eur Respir J 2013; 41: 360-367
Year: 2013



Exercise testing in obesity and sleep apnoea
Source: International Congress 2019 – Obesity: pathophysiology, diagnostic challenges and multidisciplinary treatment
Year: 2019


Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011



Phenotyping comorbidity in obstructive sleep apnea syndrome
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015

Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014

Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019


Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities?
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Disturbed sleep in obstructive sleep apnoea expressed in a single index of sleep disturbance (SDI)
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008

Obstructive sleep apnoea is not associated with endothelial dysfunction in a sleep clinic population
Source: Eur Respir J 2003; 22: Suppl. 45, 567s
Year: 2003

Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

Sleep, sleep-disordered breathing and metabolic consequences
Source: Eur Respir J 2009; 34: 243-260
Year: 2009



Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy?
Source: Eur Respir J 2013; 41: 368-375
Year: 2013